Croda has announced it has completed the acquisition of IRB (Istituto di Ricerche Biotecnologiche SpA.), the Italy-based world leader in the emerging market of active ingredients obtained by plant stem cell culture.
The move is said to strengthen the company's investment in innovative and sustainable personal care ingredients as "IRB’s reproducible products combined with Sederma’s extensive performance testing and claims validation will gaurantee efficacy previously unknown in plant extraction."
IRB uses an exclusive biotech method for sourcing plant stem cell ingredients, which is said to be fast, sustainable and eco-friendly, and provides products of guaranteed purity, which are non-GMO and free from pollutants.
According to Croda, IRB’s products will be added to the Sederma product portfolio, and will benefit from significant investment as part of the Croda group.